Companies › RXST

RXSIGHT INC (RXST)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001111485 · EDGAR filings · Updated 2026-07-24

RXSIGHT INC (RXST) has reported institutional ownership of 92.3%, with 163 institutional managers holding positions valued at $235.2M per the latest 13F reporting period.

Filings this week (3)

• 2026-07-24 — Insider transaction reported (Form 4)
• 2026-07-24 — Initial insider ownership filed (Form 3)
• 2026-07-23 — Employee-plan registration (S-8) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-17 — SCHEDULE 13G filed
• 2026-07-15 — Current report (8-K) filed
• 2026-07-06 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, RXSIGHT INC has 163 institutional holders and institutional ownership of 92.3%.

Insider activity

Insiders reported 17 transactions (0 buys, 0 sells) across 14 reporting insiders, with a net reported value of $0.

Related companies

AGOMAB THERAPEUTICS NV (AGMB) · PROTARA THERAPEUTICS INC (TARA) · LYELL IMMUNOPHARMA INC (LYEL) · STRATA CRITICAL MEDICAL INC (SRTA) · OVID THERAPEUTICS INC (OVID) · Minerva Neurosciences Inc (NERV)